FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:1441-1443 October 4, 2007 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Howard, R. J. PubMed Citation

Although cognitive deficits are the clinical hallmark of dementia syndromes, noncognitive symptoms are common and can dominate the disease course. These include a range of neuropsychiatric symptoms, such as agitation, delusions, hallucinations, repetitive vocalizations, and wandering. Neuropsychiatric symptoms develop in as many as 60% of community-dwelling patients with dementia¹ and in more than 80% of patients living in nursing homes. These symptoms are associated with greater morbidity, higher costs of care, and reduced quality of life for the patient as well as increased burden and depression for the caregiver. Indeed, neuropsychiatric symptoms are a primary predictor of nursing home placement.² . . . [Full Text of this Article]

Source Information

From the Department of Psychiatry, Neurology, and Epidemiology, University of California, San Francisco.

This article has been cited by other articles:

• (2007). Treating Agitation in Alzheimer Disease. JWatch Neurology 2007: 2-2 [Full Text]  
• (2007). Cholinesterase Inhibitors for Agitation? Not So Fast. JWatch Psychiatry 2007: 3-3 [Full Text]